Board of Directors

Peter Cohen

Mr. Cohen previously served on the Board of Directors at the NYSE, as well as previously serving as the CEO and Chairman of the Board of Cowen Inc. Read More

Peter Cohen

Lead Director
Jon Mogford

Dr. Jon Mogford, has served in various capacities for the Texas A&M University System. Since May 2013, Dr. Mogford has served as the Vice Chancellor for Research, from August 2012. Read More

Jon Mogford, PhD

Director
Minnie Baylor-Henry

Minnie Baylor-Henry is a regulatory affairs leader who provides regulatory strategic support services to life sciences companies through her consulting firm Read More

Minnie Baylor-Henry, JD

Director
Willie Bogan

Willie Bogan, JD served as Associate General Counsel and Corporate Secretary of McKesson Corporation, a San Francisco-based healthcare services and information technology company. Read More

Willie Bogan, JD

Director
Steve Gorlin

Steve Gorlin has founded several biotechnology and pharmaceutical companies, including Hycor Biomedical, Inc. (acquired by Agilent) Read More

Steve Gorlin

Director
Jeff Dyer

Jeff Dyer is the Horace Beesley professor of strategy at Brigham Young University (BYU), as well as a professor of strategy at the Wharton School, University of Pennsylvania. Read More

Jeff Dyer, MBA, PhD

Director
Ramses (Rainer) Erdtmann

Mr. Erdtmann is a Managing Partner at Point Sur Investors, a biotech investment fund focused on innovative therapies. Read More

Ramses (Rainer) Erdtmann

Director
David Seaburg *

David Seaburg serves as President of Corporate Development under the Office of the Chief Executive. He is also a member of the Board of Directors. Read More

David Seaburg *

President of Corporate Development & Board Member
Denver Lough

Dr. Denver Lough has always sought to investigate reality, pursue complex simplicity and develop a new paradigm in translational science. Read More

Denver Lough, MD, PhD

Chairman of the Board
* Serves in the Office of the Chief Executive